Öйú365betÖÐÎĹÙÍø

C&EN Webinar

Targeted Protein Degradation - New Modalities and Design Technologies

DETAILS:

On-demand virtual event

TOPICS:

Biological & Medicinal Chemistry
Physical Chemistry
Safety
Analytical Chemistry

Brought to you by:

Hear from two leading experts in drug discovery as they explore innovative approaches to targeting previously undruggable proteins. Dr. Bernhard Fasching from Monte Rosa Therapeutics will present their QuEEN� platform, which combines AI-powered chemistry and high-throughput screening to discover molecular glue degraders (MGDs). Dr. Benedict Cross from PhoreMost will share insights on their unique approach using engineered mini-proteins and phenotypic screening to enable small molecule drug discovery, particularly focusing on the Ubiquitin Proteasome System (UPS).

Speakers

Bernhard Johannes Fasching, PhD

VP Chemistry, Monte Rosa Therapeutics

Benedict James Cross, PhD

CTO, PhoreMost Therapeutics

Related Events:

C&EN Webinar
May 20, 2025 | 11 AM�12 PM ET

From Discovery to Cure: Addressing the Challenges of Oncology Drug Discovery
C&EN Webinar
On-Demand

Rapid Delivery of API Enables Accelerated IND Application� Challenges and Solutions
C&EN Webinar
On-Demand

Advanced Liquid Characterization Methods Critical for Research, New Product Development, and Quality Control
C&EN Webinar
On-Demand

Maximize Downstream Control and Efficiency with In-line Concentration Measurement
C&EN Webinar
On-Demand

Maximize Downstream Control and Efficiency with In-line Concentration Measurement

ACS Institute

Keep learning. Excel in your career.

Choose from more than 200 courses in seven different categories, taught by experts in the chemistry community, online and in person.